UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058
WASHINGTON, D.C. 20549 Estimated average burden
Hours per response . . . . . . 2.50
FORM 12b-25 SEC FILE NUMBER 2-82655
CUSIP NUMBER
NOTIFICATION OF LATE FILING
(Check One): X Form 10-K Form 20-F Form 11-K
Form 10-Q Form N-SAR
For Period Ended: December 31, 1998
Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
For the Transition Period Ended:
Read Instructions (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the item(s) to which the notification relates:
PART I - REGISTRANT INFORMATION
Full Name of Registrant
Full Name of Registrant
InterWest Medical Corporation
Former Name if Applicable Not Applicable
Address or Principal Executive Office (Street and Number)
3221 Hulen Street, Suite C
City, State and Zip Code
Fort Worth, TX 76107-6193
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate.)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report of transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed
due date; and
c. The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III - NARRATIVE
Stage below in reasonable detail the reasons why the Form 10-K, 10-Q, N-SAR
or the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach Extra Sheets If Needed)
Independent accountant is unable to complete audit and furnish opinion by
the prescribed due date of Form 10-K.
SEC 1344 (11-91)
PART IV - OTHER INFORMATION
1. Name and telephone number of person to contact in regard to this
notification.
Arch B. Gilbert, President 817 731-2743
(Name) (Area Code) (Telephone Number)
2. Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months (or for such shorter) period that
the registrant was required to file such reports) been filed? If answer is
no, identify report(s). X Yes No
3. Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof? Yes X No
If so, attach an explanation of the anticipated change, both narratively
and quantitatively and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
InterWest Medical Corporation
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date March 26,1999 By Arch B. Gilbert, President
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments
thereto must be completed and filed with the Securities and Exchange
Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
General Rules and Regulations under the Act. The information contained in or
filed with the form will be made a matter of public record in the Commission
files.
3. A manually signed copy of the form and amendments thereto shall be filed
with each national securities exchange on which any class of securities of
the registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but need
not restate information that has been correctly furnished. The form shall be
clearly identified as an amended notification.
5. Electronic Filers. This form shall not be used by electronic filers unable
to timely file a rpeort solely due to electronic difficulties. Filers unable
to submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of Regulation
S-T or apply for an adjustment in filing date pursuant to Rule 13(b) of
Regulation S-T.
March 26, 1999
United States Securities
And Exchange Commission
Washington, D.C. 20549
Re: Form 10-K
InterWest Medical Corporation
Commission File No. 2-82655
Dear Sir:
We are unable to complete our audit of the above registrant and unable to
furnish our opinion on the registrant's financial statements for the year
ended December 31, 1998 within the prescribed time period.
We anticipate completion of our audit and furnishing our opinion on InterWest
Medical Corporation's financial statements for the year ended December 31,
1998 by April 14, 1999.
Sincerely,
WEAVER AND TIDWELL, L.L.P.
Tommy Lawler
TDL:cm
